Prophylactic haloperidol: too early to lose hope - author's reply

Affiliations

Comment

Valerie J Page. Lancet Respir Med. 2013 Oct.

. 2013 Oct;1(8):e28.

doi: 10.1016/S2213-2600(13)70194-2. Epub 2013 Oct 7.

¹ Intensive Care Unit, Watford General Hospital, Watford WD18 0HB, UK. Electronic address: valerie.page@whht.nhs.uk.

No abstract available

Comment on

Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial.
Page VJ, Ely EW, Gates S, Zhao XB, Alce T, Shintani A, Jackson J, Perkins GD, McAuley DF. Page VJ, et al. Lancet Respir Med. 2013 Sep;1(7):515-23. doi: 10.1016/S2213-2600(13)70166-8. Epub 2013 Aug 21. Lancet Respir Med. 2013. PMID: 24461612 Free PMC article. Clinical Trial.
Hope for haloperidol in delirium.
van den Boogaard M, Pickkers P. van den Boogaard M, et al. Lancet Respir Med. 2013 Oct;1(8):e27. doi: 10.1016/S2213-2600(13)70210-8. Epub 2013 Oct 7. Lancet Respir Med. 2013. PMID: 24461669 No abstract available.
Prophylactic haloperidol: too early to lose hope.
Viana MV, Moraes RB, Tonietto TA, Boniatti MM. Viana MV, et al. Lancet Respir Med. 2013 Oct;1(8):e27-e28. doi: 10.1016/S2213-2600(13)70193-0. Epub 2013 Oct 7. Lancet Respir Med. 2013. PMID: 24461670 No abstract available.